Inogen, Inc. (INGN)Healthcare | Medical Devices | Beverly, United States | NasdaqGS
6.34 USD
-0.08
(-1.246%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 11:33 a.m. EDT
The investment case for Inogen is currently broken by a severe fundamental deterioration that outweighs any speculative hope of a turnaround. The company is trading at a fraction of its book value ($6.18 vs $6.54) because it is actively destroying shareholder capital: it reported negative free cash flow (-$1.7M) and negative operating cash flow (-$2.5M) while posting a -13% return on equity. The balance sheet is fragile, with debt-to-equity at 9%, indicating that the company is leveraged against a backdrop of shrinking earnings power. The price history confirms this structural decay. Over the last nine years, the stock has lost 86.6% of its value. While there was a brief resurgence in 2024, the most recent annual performance shows another decline, capping a decade-long trend of value destruction. The market has correctly priced this as a failing business; a low P/E here is not a bargain, but a reflection of zero expected growth and persistent losses. Short-term, the sentiment remains bearish. Options data reveals a massive skew toward put buying, with investors aggressively hedging against further drops rather than betting on a recovery. The statistical forecast model offers no help, showing a weak, statistically insignificant lean downward. With no dividend to provide income and a trajectory of consistent underperformance, this security warrants avoidance until the cash burn stops and profitability returns. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.144223 |
| AutoETS | 0.145646 |
| AutoTheta | 0.149440 |
| AutoARIMA | 0.150917 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 4.74 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.009 |
| Excess Kurtosis | 0.50 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.032 |
| Revenue per Share | 13.046 |
| Market Cap | 168,253,056 |
| Forward P/E | -39.63 |
| Beta | 1.50 |
| Profit Margins | -6.94% |
| Website | https://www.provider.inogen.com |
As of Oct. 10, 2026, 11:33 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put open interest significantly exceeds call open interest across all expirations, with heavy concentration in out-of-the-money strikes (e.g., $5.00 puts vs. $10.00 calls). This distribution suggests a 'bear put spread' mentality where traders are betting on continued weakness or seeking cheap insurance against further drops, rather than anticipating a rally.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.24647886 |
| Address1 | 500 Cummings Center |
| Address2 | Suite 2800 |
| All Time High | 287.79 |
| All Time Low | 4.13 |
| Ask | 8.17 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 388,260 |
| Average Daily Volume3 Month | 296,957 |
| Average Volume | 296,957 |
| Average Volume10Days | 388,260 |
| Beta | 1.498 |
| Bid | 4.63 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 6.542 |
| City | Beverly |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 2 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.34 |
| Current Ratio | 2.74 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 6.5 |
| Day Low | 6.32 |
| Debt To Equity | 9.032 |
| Display Name | Inogen |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,050,000 |
| Earnings Call Timestamp Start | 1,786,050,000 |
| Earnings Timestamp | 1,786,046,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -8,085,000 |
| Ebitda Margins | -0.022820001 |
| Enterprise To Ebitda | -9.71 |
| Enterprise To Revenue | 0.222 |
| Enterprise Value | 78,508,056 |
| Eps Current Year | -0.28 |
| Eps Forward | -0.16 |
| Eps Trailing Twelve Months | -0.92 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.6344 |
| Fifty Day Average Change | 0.70560026 |
| Fifty Day Average Change Percent | 0.12523077 |
| Fifty Two Week Change Percent | -24.647886 |
| Fifty Two Week High | 9.13 |
| Fifty Two Week High Change | -2.79 |
| Fifty Two Week High Change Percent | -0.30558598 |
| Fifty Two Week Low | 5.045 |
| Fifty Two Week Low Change | 1.2950001 |
| Fifty Two Week Low Change Percent | 0.25668982 |
| Fifty Two Week Range | 5.045 - 9.13 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,392,388,200,000 |
| Float Shares | 23,126,834 |
| Forward Eps | -0.16 |
| Forward P E | -39.625 |
| Free Cashflow | -1,768,500 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 753 |
| Fullday Change | -0.07999992 |
| Fullday Change Percent | -1.2461047 |
| Fullday Price | 6.34 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.44506 |
| Gross Profits | 157,687,008 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12945 |
| Held Percent Institutions | 0.80361 |
| Implied Shares Outstanding | 26,538,337 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts. |
| Long Name | Inogen, Inc. |
| Market | us_market |
| Market Cap | 168,253,056 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_7701753 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -24,595,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 135,106,673 |
| Number Of Analyst Opinions | 2 |
| Open | 6.44 |
| Operating Cashflow | -2,515,000 |
| Operating Margins | -0.05134 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 805 562 0500 |
| Previous Close | 6.42 |
| Price Eps Current Year | -22.642859 |
| Price Hint | 2 |
| Price To Book | 0.96912265 |
| Price To Sales Trailing12 Months | 0.47488332 |
| Profit Margins | -0.06942 |
| Quick Ratio | 2.141 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | -0.0799999 |
| Regular Market Change Percent | -1.2461 |
| Regular Market Day High | 6.5 |
| Regular Market Day Low | 6.32 |
| Regular Market Day Range | 6.32 - 6.5 |
| Regular Market Open | 6.44 |
| Regular Market Previous Close | 6.42 |
| Regular Market Price | 6.34 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 293,052 |
| Return On Assets | -0.05844 |
| Return On Equity | -0.1314 |
| Revenue Growth | 0.03 |
| Revenue Per Share | 13.046 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 26,538,337 |
| Shares Percent Shares Out | 0.0555 |
| Shares Short | 1,473,603 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,462,458 |
| Short Name | Inogen, Inc |
| Short Percent Of Float | 0.056599997 |
| Short Ratio | 4.32 |
| Source Interval | 15 |
| State | MA |
| Symbol | INGN |
| Target High Price | 12.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 12.0 |
| Target Median Price | 12.0 |
| Total Cash | 105,539,000 |
| Total Cash Per Share | 3.977 |
| Total Debt | 15,794,000 |
| Total Revenue | 354,304,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.92 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.22235 |
| Two Hundred Day Average Change | 0.11765003 |
| Two Hundred Day Average Change Percent | 0.018907651 |
| Type Disp | Equity |
| Volume | 293,052 |
| Website | https://www.provider.inogen.com |
| Zip | 1,915 |